Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone

BACKGROUND AND OBJECTIVES: The time-course when changes in glycemic control and body weight were first manifest in patients with type 2 diabetes mellitus (T2DM) treated with a combination of insulin degludec and liraglutide (IDegLira) was assessed, comparing IDegLira to its individual components. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilsbøll, Tina, Vora, Jiten, Jarlov, Henrik, Kvist, Kajsa, Blonde, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801992/
https://www.ncbi.nlm.nih.gov/pubmed/26894800
http://dx.doi.org/10.1007/s40261-016-0376-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801992/
https://www.ncbi.nlm.nih.gov/pubmed/26894800
http://dx.doi.org/10.1007/s40261-016-0376-0

Ejemplares similares